Deuterium Capital Management’s Kronos Bio KRON Stock Holding History
Bought
Maintained
Sold
Deuterium Capital Management's KRON Position: Q2 2025 in Review
Deuterium Capital Management sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 146,745 shares — an estimated $121K sold.
Deuterium Capital Management first reported a position in KRON in Q1 2025 and held it in 1 quarter. The position peaked at $121K in Q1 2025. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.
- Deuterium Capital Management reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
- Deuterium Capital Management sold 146,745 Kronos Bio shares in Q2 2025, an estimated $121K.
- Deuterium Capital Management first reported a position in Kronos Bio in Q1 2025 and held it in 1 quarter.
- Deuterium Capital Management's Kronos Bio position peaked at $121K in Q1 2025.
- 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.
Based on Deuterium Capital Management's 13F filing for Q2 2025, filed 4 Aug 2025.